Pfizer Inc. v. Sanofi Pasteur Inc. (Fed. Cir. 2024) | McDonnell Boehnen Hulbert & Berghoff LLP
Last week, the Federal Circuit handed down its opinion in Pfizer Inc. v. Sanofi Pasteur Inc., affirming the Patent Trial and Appeal Board's (PTAB) determination that all claims of U.S....
Source: jdsupra.com